超声造影评价微波消融子宫腺肌病的疗效及应用价值

Effect and Application Value of Contrast-Enhanced Ultrasound in Treatment of Percutaneous Microwave Ablation for Uterine Adenomyosis

目的探讨超声造影(Contrast Enhanced Ultrasound,CEUS)评价经皮穿刺微波消融(Percutaneous Microwave Ablation,PMWA)子宫腺肌病的疗效及应用价值。方法 31例PMWA术前经增强MRI证实为子宫腺肌病患者,分别于PMWA术前及术后1~2 d行CEUS检查,术后复查增强MRI,分析CEUS评价消融范围的准确性。术中及术后密切观察有无并发症及近期临床治疗效果。结果 31例子宫腺肌病行PMWA治疗后,CEUS显示子宫腺肌瘤消融后无造影剂灌注,消融体积为(49.4±29.8)cm3,CEUS及增强MRI测得消融区体积测值差异无统计学意义(P>0.05),PMWA治疗后痛经和贫血等症状明显缓解。结论 CEUS可准确评价微波消融子宫腺肌病疗效,值得临床应用。

Objective To explore the effect and application value of Contrast Enhanced Ultrasound (CEUS) in treatment of Percutaneous Microwave Ablation (PMWA) for uterine adenomyosis. Methods 31 patients who were diagnosed as uterine adenomyosis by contrast-enhanced MRI voluntarily underwent PMWA. CEUS was performed before and after PMWA 1～2 d, contrast-enhanced MRI was also performed after the treatment. Analysis the accuracy of ablation range detected by CEUS after PMWA treatment. Results After PMWA treatment of 31 cases of uterine adenomyosis, CEUS showed that there was no contrast agent perfusion after ablation of uterine fibroids, and the ablation volume was (49.4+29.8) cm3. The volumes detected by CEUS and contrast-enhance MRI showed no significant statistical differences (P>0.05), the symptoms such as dysmenorrhea and anemia were obviously relieved after PMWA treatment. Conclusions CEUS can accurately evaluate the effect of microwave ablation uterine adenomyosis, which is worthy of clinical application.